Normal view

There are new articles available, click to refresh the page.
Today — 25 October 2025Main stream
Before yesterdayMain stream

Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

23 October 2025 at 17:00
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.

© Audra Melton for The New York Times

Enbrel, a once-a-week injection used to treat a variety of autoimmune conditions, first arrived on the market nearly 30 years ago.
❌
❌